FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (II-A) or pharmaceutically acceptable salt thereof: 
[in which symbols denote the following: R10-R12: are identical or different and each denotes halogen, lower alkyl, halogen-lower alkyl, -OR0, -O-halogen-lower alkyl or -CN, R13: R0, halogen, halogen-lower alkyl, -OR0, -O-halogen-lower alkyl or -CN, ring B: benzene ring or a 5-6-member heteroaromatic ring containing 1-2 heteroatoms selected from O, S and N, R14: R0, halogen or -OR0, R0: are identical or different and each denotes H or lower alkyl, Y1: a single bond, lower alkylene, lower alkenylene or O-lower alkylene-, and Z1: -CO2R0 or -C0-NH-SO2-lower alkyl]. The invention also relates to a pharmaceutical composition based on the said compound, having antagonistic effect on the EP1 receptor.
EFFECT: obtaining novel compounds and a pharmaceutical composition based on said compounds, which can be used in a medicinal agent for treating lower urinary tract symptoms.
6 cl, 56 tbl, 231 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SULFONAMIDE COMPOUNDS AND SALTS THEREOF | 2009 |
|
RU2481329C2 |
| SUBSTITUTED AMIDE COMPOUNDS | 2010 |
|
RU2609021C2 |
| ARYLCARBONYL DERIVATIVES AS THERAPEUTIC AGENTS | 2003 |
|
RU2340605C2 |
| BENZAZEPIN DERIVATIVES APPLICABLE AS VASOPRESSIN ANTAGONISTS | 2008 |
|
RU2471784C2 |
| USE OF EP4 RECEPTOR ANTAGONIST IN TREATMENT OF CARTILAGE DISEASE | 2014 |
|
RU2663620C2 |
| DERIVATIVE OF 4,4-DIFLUORO-1,2,2,4-TETRAHYDRO-5H-1-BENZAZEPINE AND ITS SALT | 2004 |
|
RU2326868C2 |
| AMID DERIVATIVE | 2004 |
|
RU2336273C2 |
| DERIVATIVE OF 4,4-DIFLUORO-1,2,3,4-TETRAHYDRO-5H-BENZAZEPINE, ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | 2002 |
|
RU2268882C1 |
| DERIVATIVE OF CYCLIC AMIDE, OBTAINING SAID DERIVATIVE AND USE | 2005 |
|
RU2361861C2 |
| PIPERIDINE DERIVATIVE | 2008 |
|
RU2470020C2 |
